• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Table D.5Results of sensitivity analysis using levels of diagnostic accuracy from the second study245

InvestigationCostEffectiveness (correct diagnoses)Incremental cost (additional cost of PCT over CRP)Incremental effectiveness (additional correct diagnosis)Additional cost per additional correct diagnosis
CRP£1,500757
PCT£9,000788£7,50031£246

From: Appendix D, Economic evaluation of C-reactive protein versus procalcitonin

Cover of Feverish Illness in Children
Feverish Illness in Children: Assessment and Initial Management in Children Younger than 5 Years.
NICE Clinical Guidelines, No. 47.
National Collaborating Centre for Women’s and Children’s Health (UK).
London (UK): RCOG Press; 2007 May.
Copyright © 2007, National Collaborating Centre for Women’s and Children’s Health.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.